Universitaetsmedizin Goettingen
Göttingen, Lower Saxony 37075
2 studies enrolling now · 11 studies all time
What they study most
Acute Respiratory Distress Syndrome, Adult, Alzheimer's Disease, Alzheimer's Disease Dementia, Brain Contusion, Cancer of the Prostate, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Heart Failure, Heart Failure With Reduced Ejection Fraction, Hormone Sensitive Prostate Cancer, Lupus Erythematosus, Systemic, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Mild Cognitive Impairment Due to Alzheimer's Disease
Studies at this site
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
- Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
- Add-on Reparixin in Adult Patients With ARDS — Completed
- A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis — Running, not enrolling
- A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
- A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion — Stopped early
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Completed